T. Rowe Price Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.7M Sell
1,564,263
-99,459
-6% -$4.63M 0.01% 668
2025
Q4
$72.5M Sell
1,663,722
-1,496,014
-47% -$68.3M 0.01% 704
2025
Q3
$142M Sell
3,159,736
-1,237,280
-28% -$54.3M 0.02% 540
2025
Q2
$191M Sell
4,397,016
-11,655,576
-73% -$519M 0.02% 441
2025
Q1
$740M Sell
16,052,592
-11,565,463
-42% -$483M 0.09% 210
2024
Q4
$1.04B Buy
27,618,055
+7,483,873
+37% +$290M 0.12% 156
2024
Q3
$816M Buy
20,134,182
+17,906,896
+804% +$673M 0.09% 194
2024
Q2
$77.1M Buy
2,227,286
+836,601
+60% +$30.9M 0.01% 602
2024
Q1
$52.2M Buy
1,390,685
+16,661
+1% +$595K 0.01% 719
2023
Q4
$49.3M Buy
1,374,024
+13,395
+1% +$516K 0.01% 717
2023
Q3
$51.4M Sell
1,360,629
-8,501
-0.6% -$346K 0.01% 677
2023
Q2
$55.8M Sell
1,369,130
-174,462
-11% -$7.21M 0.01% 672
2023
Q1
$64.7M Sell
1,543,592
-3,778,129
-71% -$157M 0.01% 611
2022
Q4
$230M Sell
5,321,721
-6,609,067
-55% -$261M 0.04% 349
2022
Q3
$447M Buy
11,930,788
+9,899,186
+487% +$438M 0.07% 241
2022
Q2
$92.1M Sell
2,031,602
-3,764,701
-65% -$177M 0.01% 689
2022
Q1
$276M Sell
5,796,303
-22,608,370
-80% -$958M 0.03% 447
2021
Q4
$1.17B Sell
28,404,673
-7,355,129
-21% -$277M 0.11% 189
2021
Q3
$1.23B Buy
35,759,802
+2,038,563
+6% +$69.7M 0.12% 187
2021
Q2
$1.07B Sell
33,721,239
-1,588,430
-4% -$51.1M 0.1% 217
2021
Q1
$1.1B Buy
35,309,669
+4,347,042
+14% +$131M 0.11% 206
2020
Q4
$932M Buy
30,962,627
+2,018,613
+7% +$59.6M 0.1% 223
2020
Q3
$738M Buy
28,944,014
+2,490,642
+9% +$66M 0.09% 240
2020
Q2
$685M Buy
26,453,372
+23,662,168
+848% +$628M 0.09% 240
2020
Q1
$73.3M Buy
2,791,204
+217,934
+8% +$6.85M 0.01% 663
2019
Q4
$83.7M Sell
2,573,270
-2,820,870
-52% -$91.3M 0.01% 724
2019
Q3
$186M Buy
5,394,140
+2,859,111
+113% +$96M 0.03% 467
2019
Q2
$86.7M Buy
2,535,029
+39,658
+2% +$1.4M 0.01% 688
2019
Q1
$89.2M Buy
2,495,371
+95,120
+4% +$3.24M 0.01% 672
2018
Q4
$77.2M Sell
2,400,251
-5,264,665
-69% -$168M 0.01% 674
2018
Q3
$239M Sell
7,664,916
-281,434
-4% -$8.66M 0.03% 439
2018
Q2
$241M Sell
7,946,350
-844,297
-10% -$24.2M 0.04% 427
2018
Q1
$245M Sell
8,790,647
-9,683,535
-52% -$261M 0.04% 410
2017
Q4
$519M Sell
18,474,182
-24,058,143
-57% -$691M 0.08% 246
2017
Q3
$1.14B Sell
42,532,325
-2,136,941
-5% -$57.2M 0.2% 116
2017
Q2
$1.15B Sell
44,669,266
-2,685
-0% -$68.3K 0.21% 111
2017
Q1
$1.15B Sell
44,671,951
-15,839,401
-26% -$404M 0.21% 116
2016
Q4
$1.53B Buy
60,511,352
+1,718,493
+3% +$40.7M 0.3% 81
2016
Q3
$1.4B Buy
58,792,859
+7,189,668
+14% +$181M 0.28% 83
2016
Q2
$1.34B Buy
51,603,191
+9,561,162
+23% +$237M 0.28% 83
2016
Q1
$1.08B Buy
42,042,029
+26,071,638
+163% +$584M 0.23% 112
2015
Q4
$316M Sell
15,970,391
-12,451,782
-44% -$252M 0.07% 299
2015
Q3
$602M Sell
28,422,173
-20,593,418
-42% -$463M 0.13% 182
2015
Q2
$1.1B Buy
49,015,591
+3,116,688
+7% +$74.7M 0.23% 111
2015
Q1
$1.1B Buy
45,898,903
+3,881,081
+9% +$96.1M 0.23% 113
2014
Q4
$1.11B Buy
42,017,822
+5,416,837
+15% +$139M 0.24% 107
2014
Q3
$890M Sell
36,600,985
-610,152
-2% -$14.3M 0.19% 129
2014
Q2
$968M Buy
37,211,137
+2,997,806
+9% +$76.4M 0.21% 121
2014
Q1
$819M Buy
34,213,331
+3,372,460
+11% +$71M 0.18% 143
2013
Q4
$603M Sell
30,840,871
-460,285
-1% -$9.26M 0.14% 181
2013
Q3
$662M Sell
31,301,156
-901,960
-3% -$19.7M 0.17% 161
2013
Q2
$709M Buy
+32,203,116
New +$781M 0.19% 138

Other funds holding EXC

T. Rowe Price Associates's EXC Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Exelon (EXC) stake by 6% in Q1 2026, selling an estimated $4.63M and leaving 1,564,263 shares worth $76.7M. The position accounts for 0.01% of the portfolio, ranked #668.

T. Rowe Price Associates first reported a position in EXC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.53B in Q4 2016. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • T. Rowe Price Associates held 1,564,263 shares of Exelon worth $76.7M as of Q1 2026.
  • T. Rowe Price Associates sold 99,459 Exelon shares in Q1 2026, an estimated $4.63M.
  • Exelon made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #668 holding.
  • T. Rowe Price Associates first reported a position in Exelon in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Exelon position peaked at $1.53B in Q4 2016.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.